· Published by Health Canada · Official notice
This is duplicated text of a letter from Guidant Canada Corporation.Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
June 24, 2005
Subject: Important Safety Information on Contak Renewal® 3 and 4, Renewal 3 and 4 AVT®, and Renewal RF implantable cardiac defibrillators
Dear Health Care Professional:
This letter is intended to inform you of important safety information regarding all serial numbers of Contak Renewal 3 and 4, Renewal 3 and 4 AVT, and Renewal RF. Our records indicate that you have implanted or are monitoring patients that have these devices. This letter is intended to advise physicians and their patients about the problem and to limit adverse events. At this time, we are in the very early stages of a diligent evaluation of the component failure described below. We will continue our evaluation and communicate with you further as more information is learned. As a precautionary measure, physicians should discontinue implants of these devices pending further notice.
Guidant's Cardiac Rhythm Management Quality System has determined that the devices listed above are subject to a component failure that may limit available therapy. Engineering analysis has determined that the magnetic switch in these devices may stick in the closed position. Four occurrences have been confirmed out of approximately 46,000 devices; a fifth occurrence is suspected but cannot be confirmed. In the four occurrences in which the device was implanted, patients and/or physicians were alerted to the condition by audible device tones that signaled the magnetic switch was closed. These four occurrences have resulted in device replacement. One occurrence occurred prior to implant. To date, there have been no patient injuries beyond device replacement.
Clinical Implications
In normal device function, application of a magnet closes the magnetic switch and enables the magnet mode that controls temporary device function. If "Enable Magnet Use" is programmed "ON," as it is in default settings, and the magnetic switch becomes stuck in the closed position, treatment of ventricular or atrial tachyarrhythmias is inhibited, while bradycardia pacing is unaffected. Under these conditions, device safety features will cause the device to emit tones, and battery depletion will be accelerated. If "Enable Magnet Use" is programmed "OFF" and the magnetic switch becomes stuck in the closed position, the device will continue to provide tachyarrhythmia therapy and bradycardia pacing therapy as programmed; however, the remaining device life will be reduced significantly. Elective replacement indicators (ERI), including audible tones (if activated, as in default settings), remain intact though the time between ERI and end-of-life (EOL) indicators may be shortened.
Recommendations
We provide the following recommendations for you to consider in discussions with your patients:
Devices Impacted
All serial numbers of CONTAK RENEWAL 3 and 4, RENEWAL 3 and 4 AVT, and RENEWAL RF.
| Device Family | Model Numbers |
|---|---|
|
Table 1 footnotes
|
|
| Contak Renewal 3Table 1 footnote ** | H170, H173, H175 |
| Contak Renewal 3 HETable 1 footnote ** | H177, H179 |
| Contak Renewal 4 | H190, H195 |
| Contak Renewal 4 HE | H197, H199 |
| Contak Renewal 3 AVTTable 1 footnote ** | M150, M155 |
| Contak Renewal 3 AVT HETable 1 footnote ** | M157, M159 |
| Contak Renewal 4 AVTTable 1 footnote * | M170, M175 |
| Contak Renewal 4 AVT HETable 1 footnote * | M177, M179 |
| Renewal RFTable 1 footnote ** | H230, H235 |
| Renewal RF HETable 1 footnote ** | H239 |
A list with patients implanted with affected devices will be provided to physicians with this communication if applicable. There have been no reported injuries in Canada.
Future Actions By Guidant
We will continue to investigate this issue and we will provide any additional information that may help you care for your patients.
Further Information
We recognize the impact of this communication on both you and your patients, and want to reassure you that patient safety remains Guidant's primary concern. As always, if you have any questions regarding this communication, please contact:
The identification, characterization, and management of medical device-related adverse incidents are dependent on the active participation of health care professionals in adverse incident reporting programmes. Any occurrences of a specific adverse incident or other serious and/or unexpected adverse incidents in patients implanted with Contak Renewal® 3 and 4, Renewal 3 and 4 AVT® or Renewal RF defibrillators should be reported to Guidant Canada Corporation or Health Canada at the following addresses:
Guidant Canada Corporation
505 Apple Creek Boulevard, Unit #4
Markham, Ontario L3R 5B1
(800) 268-4487
(905) 947-5800
Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
Health Canada
Address Locator: 3002C
Ottawa, Ontario K1A 0K9
Tel: The Inspectorate Hotline 1-800-267-9675
For other inquiries, please refer to contact information:
Marketed Health Products Directorate (MHPD)
MHPD_DPSC@hc-sc.gc.ca
Tel: (613) 954-6522
Fax: (613)952-7738
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada web site.
Sincerely,
original signed by
Scott Kadwell
Country Manager, Cardiac Rhythm Management
Guidant Canada Corporation